{"id":"hrs9531-tablet","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL635","moleculeType":"Small molecule","molecularWeight":"358.43"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, there is limited information available on the exact mechanism of action of HRS9531 Tablet.","oneSentence":"HRS9531 Tablet's mechanism of action is not publicly available.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:45:47.917Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07150962","phase":"PHASE1","title":"Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects","status":"RECRUITING","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2025-10-15","conditions":"Overweight or Obesity","enrollment":168},{"nctId":"NCT06841445","phase":"PHASE2","title":"Efficacy and Safety of HRS9531 Tablet in Obese Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2025-04-07","conditions":"Chronic Management of Body Weight","enrollment":166},{"nctId":"NCT06435676","phase":"PHASE1","title":"A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2024-06-04","conditions":"Overweight or Obesity; Type 2 Diabetes","enrollment":72},{"nctId":"NCT06654960","phase":"PHASE1","title":"Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects","status":"COMPLETED","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2024-11-05","conditions":"Type 2 Diabetes","enrollment":20},{"nctId":"NCT06506175","phase":"PHASE1","title":"Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2024-08-05","conditions":"Overweight or Obese, Type 2 Diabetes","enrollment":144}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":35895,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HRS9531 Tablet","genericName":"HRS9531 Tablet","companyName":"Fujian Shengdi Pharmaceutical Co., Ltd.","companyId":"fujian-shengdi-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}